<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000028626 <NAME> LIFECORE BIOMEDICAL, INC. <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-2001 <PERIOD-START> JUL-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 273,000 <SECURITIES> 0 <RECEIVABLES> 5,963,000 <ALLOWANCES> 193,000 <INVENTORY> 21,133,000 <CURRENT-ASSETS> 18,546,000 <PP&E> 42,462,000 <DEPRECIATION> 12,596,000 <TOTAL-ASSETS> 64,223,000 <CURRENT-LIABILITIES> 2,914,000 <BONDS> 6,449,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 126,000 <OTHER-SE> 54,734,000 <TOTAL-LIABILITY-AND-EQUITY> 64,223,000 <SALES> 7,896,000 <TOTAL-REVENUES> 7,896,000 <CGS> 4,168,000 <TOTAL-COSTS> 8,295,000 <OTHER-EXPENSES> 54,000 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 216,000 <INCOME-PRETAX> (606,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (606,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (606,000) <EPS-BASIC> (.05) <EPS-DILUTED> (.05)